Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-12

AUTHORS

Atle Fretheim, Andrew D Oxman, Shaun Treweek, Arild Bjørndal

ABSTRACT

BACKGROUND: The underlying reasons for differences between clinical practice and systematically developed guidelines vary from one clinical problem to another. It is therefore logical to tailor strategies to support the implementation of guidelines to address identified barriers to change. The objective of this trial is to evaluate the effects of a tailored intervention to support the implementation of systematically developed guidelines for the use of antihypertensive and cholesterol-lowering drugs for the primary prevention of cardiovascular disease. METHODS/DESIGN: Unblinded, cluster-randomised trial. 150 general practices will be recruited from two geographical areas in Norway, and randomised to the intervention or control group (passive dissemination of guidelines). Outcomes will be measured for all eligible patients seen in the participating practices during one year after the intervention. A multifaceted intervention has been tailored to address identified barriers to change. Key components are an educational outreach visit with audit and feedback, and computerised reminders. Pharmacists will conduct the visits. During the outreach visit the main recommendations will be presented and software will be installed that links to the electronic medical record systems used in the participating practices. The software will perform an audit that will be fed back during the visit, present pop-up reminders for patients with high blood pressure or cholesterol, and provide a cardiovascular risk calculator and patient education material. The main outcomes are the proportions of 1) first time prescriptions for hypertension where thiazides are not prescribed, 2) patients not assessed for cardiovascular risk before prescribing antihypertensive or cholesterol-lowering drugs, and 3) patients treated for hypertension or high cholesterol for three months or more who have not achieved recommended treatment goals. More... »

PAGES

5

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1472-6963-3-5

DOI

http://dx.doi.org/10.1186/1472-6963-3-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015748810

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12657163


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticholesteremic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzothiadiazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Utilization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Education, Medical, Continuing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Family Practice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guideline Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Audit", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norway", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Outcome and Process Assessment (Health Care)", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmacists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Patterns, Physicians'", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Primary Prevention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium Chloride Symporter Inhibitors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Norwegian Directorate of Health", 
          "id": "https://www.grid.ac/institutes/grid.461584.a", 
          "name": [
            "Department of Health Services Research, Norwegian Directorate for Health and Social Affairs, N-0031, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fretheim", 
        "givenName": "Atle", 
        "id": "sg:person.0630240733.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630240733.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norwegian Directorate of Health", 
          "id": "https://www.grid.ac/institutes/grid.461584.a", 
          "name": [
            "Department of Health Services Research, Norwegian Directorate for Health and Social Affairs, N-0031, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oxman", 
        "givenName": "Andrew D", 
        "id": "sg:person.01207677133.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207677133.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norwegian Directorate of Health", 
          "id": "https://www.grid.ac/institutes/grid.461584.a", 
          "name": [
            "Department of Health Services Research, Norwegian Directorate for Health and Social Affairs, N-0031, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Treweek", 
        "givenName": "Shaun", 
        "id": "sg:person.0627440513.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627440513.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norwegian Directorate of Health", 
          "id": "https://www.grid.ac/institutes/grid.461584.a", 
          "name": [
            "Division of Knowledge Management, Norwegian Directorate for Health and Social Affairs, N-0031, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bj\u00f8rndal", 
        "givenName": "Arild", 
        "id": "sg:person.01362642404.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362642404.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1001/jama.282.24.2340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005392432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90944-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005589899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90944-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005589899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.323.7321.1123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005732758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1472-6963-3-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007623897", 
          "https://doi.org/10.1186/1472-6963-3-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/fampra/cmg316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009884729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/chp.1340220208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021546919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/chp.1340220208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021546919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.83.1.356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039844017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005650-200108002-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045530668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005650-200108002-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045530668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(00)01212-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049960774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.325.7360.367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050224996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/080370501750183372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058342080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074634812", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075194918", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075194919", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075194920", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075204756", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075268954", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082424421", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-12", 
    "datePublishedReg": "2003-12-01", 
    "description": "BACKGROUND: The underlying reasons for differences between clinical practice and systematically developed guidelines vary from one clinical problem to another. It is therefore logical to tailor strategies to support the implementation of guidelines to address identified barriers to change. The objective of this trial is to evaluate the effects of a tailored intervention to support the implementation of systematically developed guidelines for the use of antihypertensive and cholesterol-lowering drugs for the primary prevention of cardiovascular disease.\nMETHODS/DESIGN: Unblinded, cluster-randomised trial. 150 general practices will be recruited from two geographical areas in Norway, and randomised to the intervention or control group (passive dissemination of guidelines). Outcomes will be measured for all eligible patients seen in the participating practices during one year after the intervention. A multifaceted intervention has been tailored to address identified barriers to change. Key components are an educational outreach visit with audit and feedback, and computerised reminders. Pharmacists will conduct the visits. During the outreach visit the main recommendations will be presented and software will be installed that links to the electronic medical record systems used in the participating practices. The software will perform an audit that will be fed back during the visit, present pop-up reminders for patients with high blood pressure or cholesterol, and provide a cardiovascular risk calculator and patient education material. The main outcomes are the proportions of 1) first time prescriptions for hypertension where thiazides are not prescribed, 2) patients not assessed for cardiovascular risk before prescribing antihypertensive or cholesterol-lowering drugs, and 3) patients treated for hypertension or high cholesterol for three months or more who have not achieved recommended treatment goals.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1472-6963-3-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1327417", 
        "issn": [
          "1472-6963"
        ], 
        "name": "BMC Health Services Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "name": "Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]", 
    "pagination": "5", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4b09a897d66b9c5dc617795e898c39f49c3cbd77cc1323aeb4e866b0e4874244"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12657163"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088677"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1472-6963-3-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015748810"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1472-6963-3-5", 
      "https://app.dimensions.ai/details/publication/pub.1015748810"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000549.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1472-6963-3-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-3-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-3-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-3-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1472-6963-3-5'


 

This table displays all metadata directly associated to this object as RDF triples.

210 TRIPLES      21 PREDICATES      65 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1472-6963-3-5 schema:about N0b119d208b98430aaa279792010c3ee3
2 N0b880b90dd204ed68856aee7c748ac59
3 N21e5716bda664a27ae0a79577e846a03
4 N247320be5a814f6faaedda67b4a4a4a7
5 N38ea89c8eac946848a90639d8b4c81f3
6 N434b08762e4e4dd782cca657300b7887
7 N588ffb6ad9bc4265923118703a35b49b
8 N5d44e639340a4095afce433b3203274d
9 N65904c0c801d412fab9245f1f91771f6
10 N66ab8015f65a4fb6a1a7b1837fe58d5e
11 N820e58d77e834009ab72da1a7bdb5038
12 N821567352e3944bba09777b5ab21ed24
13 N8bcd85768ece4dcd9d266fd4d364e214
14 Na37878d63c2d45839960d99b1012473d
15 Na3e691a2f3fc41609f933df6fed47ef7
16 Na92a4ad4fd904eaeb4350f8a637a8932
17 Nadcb54056a0a47b9aa48ada5926fd7a5
18 Nfb9e9e9ba9524d4983ad0ff0e40b27ca
19 anzsrc-for:11
20 anzsrc-for:1117
21 schema:author N7514596396c341a99b72312f06a2d3dc
22 schema:citation sg:pub.10.1186/1472-6963-3-3
23 https://app.dimensions.ai/details/publication/pub.1074634812
24 https://app.dimensions.ai/details/publication/pub.1075194918
25 https://app.dimensions.ai/details/publication/pub.1075194919
26 https://app.dimensions.ai/details/publication/pub.1075194920
27 https://app.dimensions.ai/details/publication/pub.1075204756
28 https://app.dimensions.ai/details/publication/pub.1075268954
29 https://app.dimensions.ai/details/publication/pub.1082424421
30 https://doi.org/10.1001/jama.282.24.2340
31 https://doi.org/10.1002/chp.1340220208
32 https://doi.org/10.1016/0140-6736(90)90944-z
33 https://doi.org/10.1016/s0002-9149(00)01212-1
34 https://doi.org/10.1080/080370501750183372
35 https://doi.org/10.1093/fampra/cmg316
36 https://doi.org/10.1097/00005650-200108002-00002
37 https://doi.org/10.1136/bmj.323.7321.1123
38 https://doi.org/10.1136/bmj.325.7360.367
39 https://doi.org/10.1161/01.cir.83.1.356
40 schema:datePublished 2003-12
41 schema:datePublishedReg 2003-12-01
42 schema:description BACKGROUND: The underlying reasons for differences between clinical practice and systematically developed guidelines vary from one clinical problem to another. It is therefore logical to tailor strategies to support the implementation of guidelines to address identified barriers to change. The objective of this trial is to evaluate the effects of a tailored intervention to support the implementation of systematically developed guidelines for the use of antihypertensive and cholesterol-lowering drugs for the primary prevention of cardiovascular disease. METHODS/DESIGN: Unblinded, cluster-randomised trial. 150 general practices will be recruited from two geographical areas in Norway, and randomised to the intervention or control group (passive dissemination of guidelines). Outcomes will be measured for all eligible patients seen in the participating practices during one year after the intervention. A multifaceted intervention has been tailored to address identified barriers to change. Key components are an educational outreach visit with audit and feedback, and computerised reminders. Pharmacists will conduct the visits. During the outreach visit the main recommendations will be presented and software will be installed that links to the electronic medical record systems used in the participating practices. The software will perform an audit that will be fed back during the visit, present pop-up reminders for patients with high blood pressure or cholesterol, and provide a cardiovascular risk calculator and patient education material. The main outcomes are the proportions of 1) first time prescriptions for hypertension where thiazides are not prescribed, 2) patients not assessed for cardiovascular risk before prescribing antihypertensive or cholesterol-lowering drugs, and 3) patients treated for hypertension or high cholesterol for three months or more who have not achieved recommended treatment goals.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree true
46 schema:isPartOf N73b307c370504b3a8057dab61d5dcb9f
47 Nd320f02def514e7cbbe0ce27312ae52a
48 sg:journal.1327417
49 schema:name Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]
50 schema:pagination 5
51 schema:productId N2c8e5679838d4ad89a61206478f80f2d
52 N5840460589bf45679d9eec13bf0dc354
53 N771c6bb2fa8f4ddf96198b5d9dd0e65e
54 Nc4d79432046a42e4afe0ccecb6fbccd0
55 Ne1b526c27e9b45c2816fb4420e032e46
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015748810
57 https://doi.org/10.1186/1472-6963-3-5
58 schema:sdDatePublished 2019-04-10T20:03
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher N5b99b532df6f49c2a3083d52d65ae6d2
61 schema:url http://link.springer.com/10.1186%2F1472-6963-3-5
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N0b119d208b98430aaa279792010c3ee3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Benzothiadiazines
67 rdf:type schema:DefinedTerm
68 N0b880b90dd204ed68856aee7c748ac59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Humans
70 rdf:type schema:DefinedTerm
71 N21e5716bda664a27ae0a79577e846a03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Outcome and Process Assessment (Health Care)
73 rdf:type schema:DefinedTerm
74 N247320be5a814f6faaedda67b4a4a4a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Guideline Adherence
76 rdf:type schema:DefinedTerm
77 N2c8e5679838d4ad89a61206478f80f2d schema:name doi
78 schema:value 10.1186/1472-6963-3-5
79 rdf:type schema:PropertyValue
80 N38ea89c8eac946848a90639d8b4c81f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Primary Prevention
82 rdf:type schema:DefinedTerm
83 N434b08762e4e4dd782cca657300b7887 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Drug Utilization
85 rdf:type schema:DefinedTerm
86 N5840460589bf45679d9eec13bf0dc354 schema:name nlm_unique_id
87 schema:value 101088677
88 rdf:type schema:PropertyValue
89 N588ffb6ad9bc4265923118703a35b49b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Cardiovascular Diseases
91 rdf:type schema:DefinedTerm
92 N5b99b532df6f49c2a3083d52d65ae6d2 schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 N5d44e639340a4095afce433b3203274d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Education, Medical, Continuing
96 rdf:type schema:DefinedTerm
97 N65904c0c801d412fab9245f1f91771f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Pharmacists
99 rdf:type schema:DefinedTerm
100 N66ab8015f65a4fb6a1a7b1837fe58d5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Family Practice
102 rdf:type schema:DefinedTerm
103 N7037780c9d974bda948472abf2af8df8 rdf:first sg:person.01207677133.38
104 rdf:rest Ndfde5de6accd4f838cabdbb22b0d6732
105 N73b307c370504b3a8057dab61d5dcb9f schema:volumeNumber 3
106 rdf:type schema:PublicationVolume
107 N7514596396c341a99b72312f06a2d3dc rdf:first sg:person.0630240733.18
108 rdf:rest N7037780c9d974bda948472abf2af8df8
109 N771c6bb2fa8f4ddf96198b5d9dd0e65e schema:name pubmed_id
110 schema:value 12657163
111 rdf:type schema:PropertyValue
112 N820e58d77e834009ab72da1a7bdb5038 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Norway
114 rdf:type schema:DefinedTerm
115 N821567352e3944bba09777b5ab21ed24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Diuretics
117 rdf:type schema:DefinedTerm
118 N8bcd85768ece4dcd9d266fd4d364e214 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Practice Patterns, Physicians'
120 rdf:type schema:DefinedTerm
121 Na37878d63c2d45839960d99b1012473d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Antihypertensive Agents
123 rdf:type schema:DefinedTerm
124 Na3e691a2f3fc41609f933df6fed47ef7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Practice Guidelines as Topic
126 rdf:type schema:DefinedTerm
127 Na92a4ad4fd904eaeb4350f8a637a8932 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Sodium Chloride Symporter Inhibitors
129 rdf:type schema:DefinedTerm
130 Nadcb54056a0a47b9aa48ada5926fd7a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Anticholesteremic Agents
132 rdf:type schema:DefinedTerm
133 Nc4d79432046a42e4afe0ccecb6fbccd0 schema:name readcube_id
134 schema:value 4b09a897d66b9c5dc617795e898c39f49c3cbd77cc1323aeb4e866b0e4874244
135 rdf:type schema:PropertyValue
136 Nd320f02def514e7cbbe0ce27312ae52a schema:issueNumber 1
137 rdf:type schema:PublicationIssue
138 Ndfde5de6accd4f838cabdbb22b0d6732 rdf:first sg:person.0627440513.79
139 rdf:rest Ne3907773e7cc461ab7e591e2aec5b79f
140 Ne1b526c27e9b45c2816fb4420e032e46 schema:name dimensions_id
141 schema:value pub.1015748810
142 rdf:type schema:PropertyValue
143 Ne3907773e7cc461ab7e591e2aec5b79f rdf:first sg:person.01362642404.97
144 rdf:rest rdf:nil
145 Nfb9e9e9ba9524d4983ad0ff0e40b27ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Medical Audit
147 rdf:type schema:DefinedTerm
148 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
149 schema:name Medical and Health Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
152 schema:name Public Health and Health Services
153 rdf:type schema:DefinedTerm
154 sg:journal.1327417 schema:issn 1472-6963
155 schema:name BMC Health Services Research
156 rdf:type schema:Periodical
157 sg:person.01207677133.38 schema:affiliation https://www.grid.ac/institutes/grid.461584.a
158 schema:familyName Oxman
159 schema:givenName Andrew D
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207677133.38
161 rdf:type schema:Person
162 sg:person.01362642404.97 schema:affiliation https://www.grid.ac/institutes/grid.461584.a
163 schema:familyName Bjørndal
164 schema:givenName Arild
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362642404.97
166 rdf:type schema:Person
167 sg:person.0627440513.79 schema:affiliation https://www.grid.ac/institutes/grid.461584.a
168 schema:familyName Treweek
169 schema:givenName Shaun
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627440513.79
171 rdf:type schema:Person
172 sg:person.0630240733.18 schema:affiliation https://www.grid.ac/institutes/grid.461584.a
173 schema:familyName Fretheim
174 schema:givenName Atle
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630240733.18
176 rdf:type schema:Person
177 sg:pub.10.1186/1472-6963-3-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007623897
178 https://doi.org/10.1186/1472-6963-3-3
179 rdf:type schema:CreativeWork
180 https://app.dimensions.ai/details/publication/pub.1074634812 schema:CreativeWork
181 https://app.dimensions.ai/details/publication/pub.1075194918 schema:CreativeWork
182 https://app.dimensions.ai/details/publication/pub.1075194919 schema:CreativeWork
183 https://app.dimensions.ai/details/publication/pub.1075194920 schema:CreativeWork
184 https://app.dimensions.ai/details/publication/pub.1075204756 schema:CreativeWork
185 https://app.dimensions.ai/details/publication/pub.1075268954 schema:CreativeWork
186 https://app.dimensions.ai/details/publication/pub.1082424421 schema:CreativeWork
187 https://doi.org/10.1001/jama.282.24.2340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005392432
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1002/chp.1340220208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021546919
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/0140-6736(90)90944-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1005589899
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s0002-9149(00)01212-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049960774
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1080/080370501750183372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058342080
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1093/fampra/cmg316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009884729
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1097/00005650-200108002-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045530668
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1136/bmj.323.7321.1123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005732758
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1136/bmj.325.7360.367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050224996
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1161/01.cir.83.1.356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039844017
206 rdf:type schema:CreativeWork
207 https://www.grid.ac/institutes/grid.461584.a schema:alternateName Norwegian Directorate of Health
208 schema:name Department of Health Services Research, Norwegian Directorate for Health and Social Affairs, N-0031, Oslo, Norway
209 Division of Knowledge Management, Norwegian Directorate for Health and Social Affairs, N-0031, Oslo, Norway
210 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...